Mobile health applications in cardiovascular research

Cardiovascular disease is the leading cause of mortality and morbidity globally. With widespread and growing use of smart phones and mobile devices, the use of mobile health (mHealth) in transmission of physiologic parameters and patient-referred symptoms to healthcare providers and researchers, as...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2018-10, Vol.269, p.265-271
Main Authors: Sarwar, Chaudhry M.S., Vaduganathan, Muthiah, Anker, Stefan D., Coiro, Stefano, Papadimitriou, Lampros, Saltz, Joel, Schoenfeld, Elinor R., Clark, Richard L., Dinh, Wilfried, Kramer, Frank, Gheorghiade, Mihai, Fonarow, Gregg C., Butler, Javed
Format: Article
Language:English
Subjects:
Biomedical Research - methods
Biomedical Research - trends
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - therapy
Clinical trials
Endpoints
Heart failure
Humans
Mobile health
Observational Studies as Topic - methods
Randomized Controlled Trials as Topic - methods
Telemedicine - methods
Telemedicine - trends
Text Messaging - trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular disease is the leading cause of mortality and morbidity globally. With widespread and growing use of smart phones and mobile devices, the use of mobile health (mHealth) in transmission of physiologic parameters and patient-referred symptoms to healthcare providers and researchers, as well as reminders and care plan applications from providers to patients, has potential to revolutionize both clinical care and the conduct of clinical trials with improved designs, data capture, and potentially lower costs. In randomized early phase proof-of-concept studies, focusing on lifestyle intervention, there is evidence that mHealth technology can improve outcomes. By contrast, results from small randomized controlled trials that tested mHealth interventions in heart failure patients were disappointing with inconsistent findings. These inconclusive results could be partially attributed to a lack of methodological rigor (insufficient sample size, quasi-experimental design, inadequate mHealth equipment). Therefore, there is an urgent need to develop systematic evidence-based guidelines and parameters for mHealth to be effectively utilized in cardiovascular clinical trials. •Incorporation of mHealth into clinical trials in cardiovascular medicine•Gaps in mHealth medicine and challenges in clinical research implementation•Array of available mHealth resources and their use in clinical trials•Strategies to adapt mHealth technology to meet research needs
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2018.06.039